Literature DB >> 24702711

Rapid and sensitive assessment of human hepatocyte functions.

Roberto Gramignoli1, Veysel Tahan, Kenneth Dorko, Raman Venkataramanan, Ira J Fox, Ewa C S Ellis, Massoud Vosough, Stephen C Strom.   

Abstract

Transplantation of human hepatocytes (HTx) has gained recognition as a bridge to, or an alternative to, orthotopic liver transplantation for patients with acute liver failure or genetic defects in liver function. Although the quality of the hepatocytes used for cell transplantation is critical, no consensus exists on protocols to assess the function of hepatocytes prior to HTx. Application of this cell therapy in clinical practice could be aided by fast and reliable assays to evaluate the functional competence of isolated hepatocytes prior to clinical transplantation. Traditional assays for measuring metabolic functions in primary hepatocytes frequently involve highly technical equipment, time-consuming methods, and large numbers of cells. We describe a novel approach for the rapid assessment of the metabolic capabilities of human hepatocytes. This report details simple procedures to evaluate 11 endpoints from cells isolated from human liver that can be performed by a single operator within approximately 2 h of isolation. Longer term cultured hepatocytes were also analyzed to determine if the results from the 2-h tests were predictive of long-term hepatic function. The assays simultaneously measure five cytochrome P450 activities, one phase II activity, plating efficiency, and ammonia metabolism in addition to viability and cell yield. The assays require fewer than 20 million cells and can be completed using commonly available and inexpensive laboratory equipment. The protocol details methods that can be used in a time frame that would allow analysis of hepatic functions in freshly isolated hepatocytes prior to their use for clinical transplantation.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24702711     DOI: 10.3727/096368914X680064

Source DB:  PubMed          Journal:  Cell Transplant        ISSN: 0963-6897            Impact factor:   4.064


  18 in total

1.  Role of Chromatin Structural Changes in Regulating Human CYP3A Ontogeny.

Authors:  Nicholas L Giebel; Jeffrey D Shadley; D Gail McCarver; Kenneth Dorko; Roberto Gramignoli; Stephen C Strom; Ke Yan; Pippa M Simpson; Ronald N Hines
Journal:  Drug Metab Dispos       Date:  2016-02-26       Impact factor: 3.922

Review 2.  Cell-based liver therapies: past, present and future.

Authors:  Valeria Iansante; Anil Chandrashekran; Anil Dhawan
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2018-07-05       Impact factor: 6.237

3.  Gene Editing Correction of a Urea Cycle Defect in Organoid Stem Cell Derived Hepatocyte-like Cells.

Authors:  Mihaela Zabulica; Tomas Jakobsson; Francesco Ravaioli; Massoud Vosough; Roberto Gramignoli; Ewa Ellis; Olav Rooyackers; Stephen C Strom
Journal:  Int J Mol Sci       Date:  2021-01-26       Impact factor: 5.923

4.  Host conditioning and rejection monitoring in hepatocyte transplantation in humans.

Authors:  Kyle A Soltys; Kentaro Setoyama; Edgar N Tafaleng; Alejandro Soto Gutiérrez; Jason Fong; Ken Fukumitsu; Taichiro Nishikawa; Masaki Nagaya; Rachel Sada; Kimberly Haberman; Roberto Gramignoli; Kenneth Dorko; Veysel Tahan; Alexandra Dreyzin; Kevin Baskin; John J Crowley; Mubina A Quader; Melvin Deutsch; Chethan Ashokkumar; Benjamin L Shneider; Robert H Squires; Sarangarajan Ranganathan; Miguel Reyes-Mugica; Steven F Dobrowolski; George Mazariegos; Rajavel Elango; Donna B Stolz; Stephen C Strom; Gerard Vockley; Jayanta Roy-Chowdhury; Marilia Cascalho; Chandan Guha; Rakesh Sindhi; Jeffrey L Platt; Ira J Fox
Journal:  J Hepatol       Date:  2016-12-24       Impact factor: 25.083

5.  Mechanistic Differences in Cell Death Responses to Metal-Based Engineered Nanomaterials in Kupffer Cells and Hepatocytes.

Authors:  Xiang Wang; Chong Hyun Chang; Jinhong Jiang; Xiangsheng Liu; Jiulong Li; Qi Liu; Yu-Pei Liao; Linjiang Li; André E Nel; Tian Xia
Journal:  Small       Date:  2020-04-26       Impact factor: 13.281

Review 6.  Human hepatocyte transplantation for liver disease: current status and future perspectives.

Authors:  V Iansante; R R Mitry; C Filippi; E Fitzpatrick; A Dhawan
Journal:  Pediatr Res       Date:  2017-12-06       Impact factor: 3.756

7.  Clinical Hepatocyte Transplantation: What Is Next?

Authors:  James E Squires; Kyle A Soltys; Patrick McKiernan; Robert H Squires; Stephen C Strom; Ira J Fox; Alejandro Soto-Gutierrez
Journal:  Curr Transplant Rep       Date:  2017-10-14

Review 8.  Human Hepatocytes Isolated from Explanted Livers: A Powerful Tool to Understand End-stage Liver Disease and Drug Screening.

Authors:  Lanuza A P Faccioli; Zehra N Kocas-Kilicarslan; Ricardo Diaz-Aragon; Takashi Motomura; Sriram Amirneni; Michelle R Malizio; Michael C Coard; Carla Frau; Nils Haep; Rodrigo M Florentino; Alina Ostrowska
Journal:  Organogenesis       Date:  2021-10-02       Impact factor: 2.316

Review 9.  The multiple functional roles of mesenchymal stem cells in participating in treating liver diseases.

Authors:  Wei-hui Liu; Fu-qiang Song; Li-na Ren; Wen-qiong Guo; Tao Wang; Ya-xing Feng; Li-jun Tang; Kun Li
Journal:  J Cell Mol Med       Date:  2014-12-23       Impact factor: 5.310

10.  De Novo Donor-Specific HLA Antibody Formation in Two Patients With Crigler-Najjar Syndrome Type I Following Human Hepatocyte Transplantation With Partial Hepatectomy Preconditioning.

Authors:  C Jorns; G Nowak; A Nemeth; H Zemack; L-M Mörk; H Johansson; R Gramignoli; M Watanabe; A Karadagi; M Alheim; D Hauzenberger; R van Dijk; P J Bosma; F Ebbesen; A Szakos; B Fischler; S Strom; E Ellis; B-G Ericzon
Journal:  Am J Transplant       Date:  2015-11-02       Impact factor: 8.086

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.